Format
Sort by
Items per page

Send to

Choose Destination

Best matches for ((rivaroxaban) OR (venous AND thromboembolism) OR (posttreatment AND followup)):

Search results

Items: 1 to 20 of 32929

1.

Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE): Domain 5-Discontinuation of anticoagulant therapy in small animals.

Brainard BM, Buriko Y, Good J, Ralph AG, Rozanski EA.

J Vet Emerg Crit Care (San Antonio). 2019 Jan;29(1):88-97. doi: 10.1111/vec.12796.

PMID:
30654425
2.

Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE): Domain 4-Refining and monitoring antithrombotic therapies.

Sharp CR, deLaforcade AM, Koenigshof AM, Lynch AM, Thomason JM.

J Vet Emerg Crit Care (San Antonio). 2019 Jan;29(1):75-87. doi: 10.1111/vec.12794.

PMID:
30654420
3.

Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE): Domain 3-Defining antithrombotic protocols.

Blais MC, Bianco D, Goggs R, Lynch AM, Palmer L, Ralph A, Sharp CR.

J Vet Emerg Crit Care (San Antonio). 2019 Jan;29(1):60-74. doi: 10.1111/vec.12795.

PMID:
30654416
4.

Rivaroxaban (Xarelto) plus aspirin for secondary prevention of cardiovascular events.

[No authors listed]

Med Lett Drugs Ther. 2018 Dec 3;60(1561):196-197. No abstract available.

PMID:
30653475
5.

Rivaroxaban for the treatment of venous thromboembolism in real life: A single-center prospective study.

Demelo-Rodríguez P, Galeano-Valle F, García-Fernández-Bravo I, Piqueras-Ruiz S, Álvarez-Sala-Walther L, Del Toro-Cervera J.

Medicine (Baltimore). 2019 Jan;98(3):e14093. doi: 10.1097/MD.0000000000014093.

PMID:
30653127
6.

Behavior of Ultrasensitive C-Reactive Protein in Myocardial Revascularization with and without Cardiopulmonary Bypass.

Abrantes RD, Hueb AC, Hueb W, Jatene FB.

Braz J Cardiovasc Surg. 2018 Nov-Dec;33(6):535-541. doi: 10.21470/1678-9741-2018-0235.

PMID:
30652741
7.

Risk of Venous Thromboembolism for Patients with Pancreatic Ductal Adenocarcinoma Undergoing Preoperative Chemotherapy Followed by Surgical Resection.

Boone BA, Zenati MS, Rieser C, Hamad A, Al-Abbas A, Zureikat AH, Hogg ME, Neal MD, Zeh HJ 3rd.

Ann Surg Oncol. 2019 Jan 16. doi: 10.1245/s10434-018-07148-z. [Epub ahead of print]

PMID:
30652227
8.

Is VTE Prophylaxis Necessary on Discharge for Patients Undergoing Adrenalectomy for Cushing Syndrome?

Babic B, De Roulet A, Volpe A, Nilubol N.

J Endocr Soc. 2018 Dec 12;3(2):304-313. doi: 10.1210/js.2018-00278. eCollection 2019 Feb 1.

PMID:
30652131
9.

Novel screening criteria for post-traumatic venous thromboembolism by using D-dimer.

Iyama K, Inokuma T, Sato S, Yamano S, Tajima G, Hirao T, Tasaki O.

Acute Med Surg. 2018 Oct 17;6(1):40-48. doi: 10.1002/ams2.375. eCollection 2019 Jan.

PMID:
30651996
10.

Venous thromboembolism in a young girl with duplication of inferior vena cava and protein S deficiency

Liao WL, Shih MY, Wang JD.

Turk J Haematol. 2019 Jan 17. doi: 10.4274/tjh.2018.0332. [Epub ahead of print] No abstract available.

PMID:
30651208
11.

Predicting VTE in Cancer Patients: Candidate Biomarkers and Risk Assessment Models.

Riondino S, Ferroni P, Zanzotto FM, Roselli M, Guadagni F.

Cancers (Basel). 2019 Jan 15;11(1). pii: E95. doi: 10.3390/cancers11010095. Review.

PMID:
30650562
12.

Re-Examining Genetic Screening and Oral Contraceptives: A Patient-Centered Review.

Hiedemann B, Vernon E, Bowie BH.

J Pers Med. 2019 Jan 15;9(1). pii: E4. doi: 10.3390/jpm9010004. Review.

PMID:
30650548
13.

Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial.

Cohen AT, Agnelli G, Buller HR, Gallus A, Raskob GE, Sanders P, Thompson J, Weitz JI.

Thromb Haemost. 2019 Jan 16. doi: 10.1055/s-0038-1676983. [Epub ahead of print]

PMID:
30650446
14.

Cardiovascular Risk Factors Associated With Venous Thromboembolism.

Gregson J, Kaptoge S, Bolton T, Pennells L, Willeit P, Burgess S, Bell S, Sweeting M, Rimm EB, Kabrhel C, Zöller B, Assmann G, Gudnason V, Folsom AR, Arndt V, Fletcher A, Norman PE, Nordestgaard BG, Kitamura A, Mahmoodi BK, Whincup PH, Knuiman M, Salomaa V, Meisinger C, Koenig W, Kavousi M, Völzke H, Cooper JA, Ninomiya T, Casiglia E, Rodriguez B, Ben-Shlomo Y, Després JP, Simons L, Barrett-Connor E, Björkelund C, Notdurfter M, Kromhout D, Price J, Sutherland SE, Sundström J, Kauhanen J, Gallacher J, Beulens JWJ, Dankner R, Cooper C, Giampaoli S, Deen JF, Gómez de la Cámara A, Kuller LH, Rosengren A, Svensson PJ, Nagel D, Crespo CJ, Brenner H, Albertorio-Diaz JR, Atkins R, Brunner EJ, Shipley M, Njølstad I, Lawlor DA, van der Schouw YT, Selmer RM, Trevisan M, Verschuren WMM, Greenland P, Wassertheil-Smoller S, Lowe GDO, Wood AM, Butterworth AS, Thompson SG, Danesh J, Di Angelantonio E, Meade T; Emerging Risk Factors Collaboration.

JAMA Cardiol. 2019 Jan 16. doi: 10.1001/jamacardio.2018.4537. [Epub ahead of print]

PMID:
30649175
15.

D-dimer Levels are not a Good Marker for Venous Thromboembolism in Patients Before and After Total Hip Replacement.

Waśko MK, Burbul M, Gawroński K, Pepłoński A, Kwiatkowski K.

Ortop Traumatol Rehabil. 2018 Oct 31;20(5):401-408. doi: 10.5604/01.3001.0012.8276.

PMID:
30648665
16.
17.

Not Just Arterial Damage: Increased Incidence of Venous Thromboembolic Events in Cardiovascular Patients With Elevated Plasma Levels of Apolipoprotein CIII.

Olivieri O, Turcato G, Moruzzi S, Castagna A, Girelli D, Pizzolo F, Friso S, Sandri M, Bassi A, Martinelli N.

J Am Heart Assoc. 2019 Jan 22;8(2):e010973. doi: 10.1161/JAHA.118.010973.

PMID:
30646800
18.

Effect of Real-time Patient-Centered Education Bundle on Administration of Venous Thromboembolism Prevention in Hospitalized Patients.

Haut ER, Aboagye JK, Shaffer DL, Wang J, Hobson DB, Yenokyan G, Sugar EA, Kraus PS, Farrow NE, Canner JK, Owodunni OP, Florecki KL, Webster KLW, Holzmueller CG, Pronovost PJ, Streiff MB, Lau BD.

JAMA Netw Open. 2018 Nov 2;1(7):e184741. doi: 10.1001/jamanetworkopen.2018.4741.

PMID:
30646370
19.

Assessment of Outcomes of Treatment With Oral Anticoagulants in Patients With Atrial Fibrillation and Multiple Chronic Conditions: A Comparative Effectiveness Analysis.

Mentias A, Shantha G, Chaudhury P, Vaughan Sarrazin MS.

JAMA Netw Open. 2018 Sep 7;1(5):e182870. doi: 10.1001/jamanetworkopen.2018.2870.

PMID:
30646182
20.

Postoperative Joint Replacement Complications in Swedish Patients With a Family History of Venous Thromboembolism.

Zöller B, Svensson PJ, Sundquist J, Sundquist K, Pirouzifard M.

JAMA Netw Open. 2018 Sep 7;1(5):e181924. doi: 10.1001/jamanetworkopen.2018.1924.

PMID:
30646144

Supplemental Content

Loading ...
Support Center